Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis. (Q34654186)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

intrahepatic cholangiocarcinoma

5 March 2020

main subject

cholangiocarcinoma

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Eleni Liapi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

13

Timothy M Pawlik

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Omar Hyder

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

J Wallis Marsh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Elena N Petre

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sanjeeva Kalva

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

David Cosgrove

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Donielle Neal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Ihab Kamel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Andrew X Zhu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Constantinos T Sofocleous

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Jean-Francois H Geschwind

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

12 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

Annals of Surgical Oncology

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

3779-3786

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23846786%20AND%20SRC:MED&resulttype=core&format=json

Intrahepatic cholangiocarcinoma.

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

The epidemiology of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Changing international trends in mortality rates for liver, biliary and pancreatic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Palliation of hepatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

The role of chemotherapy in biliary tract carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Combined hepatocellular and cholangiocarcinoma of the liver: sonography, CT, angiography, and iodized-oil CT with pathologic correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Newer Angiographic Observations in Cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Intrahepatic cholangiocarcinoma: macroscopic type and stage classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y

Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3127-Y